Flc Capital Advisors Abbott Laboratories Transaction History

Flc Capital Advisors

$430 Million
Q3 2024

A detailed history of Flc Capital Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Flc Capital Advisors holds 3,983 shares of ABT stock, worth $449,282. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,983

Previous 3,983 -0.0%

Holding current value

$449,282

Previous $413,000 9.93%

% of portfolio

0.11%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$90.19 - $110.4 $32,107 - $39,302	-356 Reduced 8.2%	3,983 $438,000
Q1 2023 Apr 26, 2023	SELL	$96.86 - $114.01 $28,089 - $33,062	-290 Reduced 6.26%	4,339 $439,000
Q4 2022 Jan 27, 2023	SELL	$95.06 - $111.52 $92,493 - $108,508	-973 Reduced 17.37%	4,629 $508,000
Q3 2022 Oct 14, 2022	BUY	$96.76 - $112.03 $2,322 - $2,688	24 Added 0.43%	5,602 $542,000
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $4,695 - $5,675	-46 Reduced 0.82%	5,578 $606,000
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $4,231 - $4,981	40 Added 0.72%	5,624 $652,000
Q3 2020 Oct 23, 2020	BUY	$91.64 - $111.29 $26,575 - $32,274	290 Added 5.48%	5,584 $605,000
Q2 2020 Jul 10, 2020	SELL	$76.57 - $98.0 $33,384 - $42,728	-436 Reduced 7.61%	5,294 $492,000
Q4 2019 Jan 13, 2020	SELL	$78.51 - $87.4 $78,510 - $87,400	-1,000 Reduced 14.86%	5,730 $498,000
Q3 2019 Oct 29, 2019	SELL	$81.84 - $88.74 $100,172 - $108,617	-1,224 Reduced 15.39%	6,730 $563,000
Q2 2019 Aug 05, 2019	BUY	$72.88 - $85.0 $59,032 - $68,850	810 Added 11.34%	7,954 $677,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $161,047 - $194,705	2,432 Added 51.61%	7,144 $571,000
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $308,918 - $349,960	4,712 New	4,712 $341,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Flc Capital Advisors with notifications on news.

Account

Flc Capital Advisors Abbott Laboratories Transaction History